Phase 3 Results for Ixekizumab Promising in Patients with Non-Radiographic Axial Spondyloarthritis
FDA Approves Ixekizumab for Treating Active Ankylosing Spondylitis
Ixekizumab vs. Adalimumab for PsA: How Do They Compare?
A New Treatment for Axial Spondyloarthritis?
Ixekizumab Promising for Non-Radiographic Axial SpA; Plus FDA Approves Belimumab for Pediatric Lupus
Rheumatology Drugs at a Glance, Part 2: Psoriasis
Rheumatology Drugs at a Glance, Part 1: Psoriatic Arthritis